Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.
Study Type
OBSERVATIONAL
Enrollment
100
Laboratoire de Bactériologie - CHU de Strasbourg - France
Strasbourg, France
RECRUITINGDescription of the clinical presentation of cases of disseminated borreliosis occurring in patients receiving anti-CD20 therapy in France
The clinical presentation describes how the disease manifests in patients: * the symptoms, * their severity, * and their progression. Example: Two patients may have the same disease, but one will primarily experience fever while the other will have neurological symptoms. This is part of the clinical presentation.
Time frame: Up to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.